Tuesday, November 2, 2010

Vicor Technologies (VCRT.OB) is Hiring

In an economy where staff reductions have become the norm, Vicor Technologies has been aggressively hiring, scaling up its sales staff for its PD2i Analyzer, a system for measuring heart rate variability. The product is one of three that Vicor offers employing the company’s proprietary point correlation dimension algorithm (PD2i®), a nonlinear algorithm and software that accurately assesses risk for various future pathological events.

The company is actively recruiting independent sales reps. across the U.S. to drive sales. Vicor’s National Sales Manager, Christopher Vissman, said that they have already recruited 12 new reps since September, and anticipate adding another 10 by the beginning of December. They are currently targeting physicians specializing in endocrinology, internal medicine, cardiology, and family medicine in Massachusetts, Maryland, North Carolina, Tennessee, Georgia, Florida, Texas, and Colorado. The additional reps will be recruited for New Jersey, Tennessee, Mississippi, Illinois, Missouri, Texas, Utah, Arizona, and California.

Vicor CEO, David Fater, said of the recruiting drive, “The sales representatives Chris is recruiting have worked with companies such as St. Jude Medical, Medtronic, Biotronik, Sorin Group, GE Healthcare, Hill-Rom, Stryker, CardioDynamics, Polymedco, Becton, Dickinson and Company, Intelli-Heart, eCardio, and CarboMedics. With backgrounds like theirs, we’re confident that the members of our new sales force are well-established among the physicians we’re targeting and will have a significant impact on our revenue growth going forward. Kudos to Chris Vissman; he has made remarkable inroads in establishing a powerful sales force for our PD2i Analyzer™ in the short time he’s been with us, which complements the international distributor agreements we have signed or are in the process of negotiating.”

Vicor Technologies is a biotechnology company, based in Florida, specializing in innovative non-invasive diagnostics that can predict future pathological events for heart and diabetic patients, and trauma victims. The core of its product line is its patented PD2i® nonlinear algorithm and software.

Additional information is available at www.VicorTech.com.

About QualityStocks:

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net

Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net

No comments: